Nalmefene and naltrexone reduce alcohol intake via selective efficacy in subpopulations distinguished by behavioral and blood-based biomarkers. [PDF]
Commun Med (Lond)Farahbakhsh ZZ +4 more
europepmc +1 more source
Use of Naltrexone-Bupropion in Persons With Overweight/Obesity and Symptoms of Depression: A Pooled Analysis. [PDF]
Obesity (Silver Spring)Tronieri JS +5 more
europepmc +1 more source
Cardiovascular effects of a selective 5-HT4 agonist and an alpha-2 adrenoceptor antagonist in etorphine immobilised sheep (Ovis aries) - a randomised, prospective, and controlled trial. [PDF]
BMC Vet ResRattanathanya H +12 more
europepmc +1 more source
Comparative Effectiveness of Naltrexone Formulations in Alcohol Use Disorder: An Updated Meta-Analysis. [PDF]
Psychopharmacol BullNunez NA, Ali HM, Hassett L, Singh B.
europepmc +1 more source
Case report: Acamprosate for treatment of volatile hydrocarbon (VHC) inhalant use disorder with comorbid alcohol use disorder. [PDF]
Ment Health ClinPiri N, Campbell W.
europepmc +1 more source
Severe Early-Onset Withdrawal Following Intentional Use of Mitragynine Pseudoindoxyl: A Case Report and Emerging Clinical Considerations. [PDF]
CureusStanciu CN.
europepmc +1 more source
Shared effects of the opioid antagonist naltrexone on first-hand and empathic pain. [PDF]
Soc Cogn Affect NeurosciBraunstein JT, Rütgen M, Lamm C.
europepmc +1 more source
Pharmacotherapy for Alcohol Craving Reduction: Efficacy of Short-Term Treatments in Alcohol Use Disorder. [PDF]
Medicines (Basel)Cheibub David Marin M +3 more
europepmc +1 more source
An Experimental Study to Evaluate the Role of Buprenorphine, Morphine, and Naltrexone in Animal Models of Depression. [PDF]
CureusSuja Nongtdu NL, Verma V.
europepmc +1 more source